SCHEMBL7673755

SCHEMBL7673755

N=C(N)c1ccc(OC(=O)c2ccc(S(=O)(=O)N[C@@H](Cc3ccccc3)C(=O)O)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 2/20 0.62
ITGA2B P08514 2/20 0.62
MMP2 P08253 9/20 0.59
MMP9 P14780 8/20 0.59
ADAMTS4 O75173 1/20 0.59
F2 P00734 2/20 0.58
TMPRSS6 Q8IU80 2/20 0.58
ADAMTS5 Q9UNA0 1/20 0.54
ALDH1A1 P00352 1/20 0.54
MAPT P10636 1/20 0.54
MMP1 P03956 1/20 0.54
MMP3 P08254 1/20 0.54
MMP7 P09237 1/20 0.54
MMP13 P45452 1/20 0.54
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7895440 1.00 ITGB3 (0.62) ITGB3ITGA2BMMP2MMP9ADAMTS4
SCHEMBL7667925 0.88 F2 (0.54) ITGB3ITGA2BMMP2MMP9F2
SCHEMBL7673572 0.88 F2 (0.54) ITGB3ITGA2BMMP2MMP9F2
SCHEMBL7665182 0.86 PRSS1 (0.56) ITGB3ITGA2B
SCHEMBL9710389 0.81 F2 (0.70) ITGB3ITGA2BF2TMPRSS6
SCHEMBL7363271 0.80 TDP1 (0.78) ITGB3ITGA2BMMP2MMP9F2
SCHEMBL7363270 0.80 TDP1 (0.78) ITGB3ITGA2BMMP2MMP9F2
SCHEMBL6081543 0.77 MMP2 (0.86) MMP2MMP9ADAMTS4ADAMTS5ALDH1A1
SCHEMBL22234044 0.77 MMP2 (0.86) MMP2MMP9ADAMTS4ADAMTS5ALDH1A1
SCHEMBL3718143 0.77 MMP2 (0.86) MMP2MMP9ADAMTS4ADAMTS5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US claimed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP claimed
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed